PUMA BIOTECHNOLOGY, INC.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2022 | $-26.9M | $-26.9M | — | $3.1M |
| Jun 2022 | $-13.9M | $-13.9M | — | $3.2M |
| Sep 2022 | $17.3M | $17.3M | — | $2.8M |
| Dec 2022 | $7.7M | $7.7M | — | $2.6M |
| Mar 2023 | $2.6M | $2.6M | — | $2.8M |
| Jun 2023 | $3.3M | $3.3M | — | $2.4M |
| Sep 2023 | $10.6M | $10.6M | — | $2.5M |
| Dec 2023 | $10.5M | $10.5M | — | $2.4M |
| Mar 2024 | $11.2M | $11.2M | $0 | $2.4M |
| Jun 2024 | $1.0M | $1.0M | $20.0K | $2.1M |
| Sep 2024 | $11.0M | $11.0M | $20.0K | $2.1M |
| Dec 2024 | $15.6M | $15.6M | $16.0K | $1.8M |
| Mar 2025 | $3.6M | $3.6M | $61.0K | $2.0M |
| Jun 2025 | $14.1M | $14.1M | $20.0K | $1.6M |
| Sep 2025 | $9.7M | $9.7M | $26.0K | $1.7M |
| Dec 2025 | $14.4M | $14.5M | $-36.0K | $1.6M |
| Mar 2026 | $15.4M | $15.4M | $0 | $1.9M |
| Jun 2026 | $1.6M | $1.6M | $0 | $2.0M |